The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine

Clinical trial NCT02387619 · COMPLETED

Trial details

NCT number: NCT02387619
Sponsor: Jeil Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension Hyperlipidemia

Start date: 2015-02-01
Primary completion: 2015-03-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.